Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

Agencies Expect Possible Treatments and Hope for a Coronavirus Vaccine as Soon as Three Months

Livemoney January 30, 2020

Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering

PR Newswire January 22, 2020

Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer

Livemoney January 22, 2020

Some U.S. Airports Begin Checking Passengers for a Deadly New Chinese Virus

Livemoney January 21, 2020

Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire January 17, 2020

Aethlon Medical Announces Closing of $5 Million Public Offering

PR Newswire December 17, 2019

Aethlon Medical Announces Pricing of $5 Million Public Offering

PR Newswire December 13, 2019

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

PR Newswire November 1, 2019

Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019

PR Newswire October 29, 2019

Aethlon Announces Reverse Stock Split

PR Newswire October 14, 2019

Aethlon Medical Announces FDA Approval Of IDE For Oncology Indications

PR Newswire October 7, 2019

Aethlon Medical Receives Extension from Nasdaq to Regain Compliance with Continued Listing Requirements

PR Newswire October 3, 2019

Aethlon Announces Collaboration to Identify Exosomes Involved in Cancer Progression and Treatment Resistance

PR Newswire September 24, 2019

Aethlon Medical Receives National Cancer Institute Contract Award

PR Newswire September 16, 2019

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

PR Newswire August 14, 2019

Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019

PR Newswire August 7, 2019

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

PR Newswire July 1, 2019

Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement

PR Newswire July 1, 2019

Aethlon Medical To Release Fiscal Year End Financial Results and Host Conference Call on July 1, 2019

PR Newswire June 19, 2019

Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies

PR Newswire May 13, 2019